TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11086369

Group type: EXPERIMENTAL
Intervention: Androstenedione 100 mg/d for 7 days
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Androstenedione 300 mg/d for 7 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: No androstenedione (control group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 19‐norandrostenedione 10 microg
Number of subjects: 41
Study: 8956447

Group type: EXPERIMENTAL
Intervention: Information-package (direct mailing) consisting of consensus recommendations, headline questions with answers, and classification of oestrogens available in Norway.
Number of subjects: 374

Group type: COMPARATOR
Intervention: Control group (no information-package).
Number of subjects: 374
Study: 1552034

Group type: EXPERIMENTAL
Intervention: Buspirone (57 +/- 7 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 14
Study: 2863089

Group type: EXPERIMENTAL
Intervention: Bromazepam (3 to 9 mg per day)
Number of subjects: 671

Group type: COMPARATOR
Intervention: Lorazepam (1 to 3 mg per day)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 671

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 671
Study: 30456414

Group type: EXPERIMENTAL
Intervention: Modified supine Double-S position
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard prone position
Number of subjects: 0
Study: 31742648

Group type: EXPERIMENTAL
Intervention: Attention Process Training (20 hours)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Activity-based attention training
Number of subjects: 59
Study: 29133798

Group type: EXPERIMENTAL
Intervention: Motivational interviewing and feedback of urine cotinine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (measurements only: questionnaires, urine cotinine, lung function)
Number of subjects: 58
Study: 25995238

Group type: EXPERIMENTAL
Intervention: Internet-based, nurse-led vascular risk factor management programme
Number of subjects: 330

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 330
Study: 23306647

Group type: COMPARATOR
Intervention: B/YP
Number of subjects: 46

Group type: COMPARATOR
Intervention: MP
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: HRT III
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: OCT
Number of subjects: 46
Study: 21646262

Group type: EXPERIMENTAL
Intervention: Instructor-only training
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Automated defibrillator feedback only
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Instructor training combined with automated feedback
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (no structured training)
Number of subjects: 89
Study: 18653575

Group type: EXPERIMENTAL
Intervention: Atazanavir
Number of subjects: 39

Group type: COMPARATOR
Intervention: Other protease inhibitors (Control)
Number of subjects: 39
Study: 16771937

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI)
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: H. pylori test-and-eradicate
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Combination of PPI and H. pylori testing
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 722

Group type: COMPARATOR
Intervention: Empirical antisecretory therapy (PPI)
Number of subjects: 722
Study: 15539531

Group type: EXPERIMENTAL
Intervention: Pain communication intervention (viewing a pain management and pain communication film)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pain management film only (control group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care only (control group)
Number of subjects: 0
Study: 11157639

Group type: EXPERIMENTAL
Intervention: Antithrombotic agents
Number of subjects: 0
Study: 9270646

Group type: EXPERIMENTAL
Intervention: Mild hypothermia during cardiopulmonary bypass
Number of subjects: 99

Group type: COMPARATOR
Intervention: Moderate hypothermia during cardiopulmonary bypass
Number of subjects: 99
Study: 7879621

Group type: EXPERIMENTAL
Intervention: Histochemical method using six biotinylated lectins to detect carbohydrates in the endolymphatic sac.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Histochemical method to detect protein in the endolymphatic sac.
Number of subjects: 15
Study: 3366521

Group type: EXPERIMENTAL
Intervention: Downhill running (215 m.min‐1 for 10,000 footstrikes at -6%)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Uphill running (215 m.min‐1 for 10,000 footstrikes at +6%)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Treadmill running (both downhill and uphill)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Resting control procedure
Number of subjects: 14
Study: 2166209

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins (LMWHs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CY 216 (once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PK 10169
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ORG 10172 and KABI 2165
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 4811950

Group type: EXPERIMENTAL
Intervention: Exercise therapy for 12 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Social therapy for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 31857298

Group type: EXPERIMENTAL
Intervention: Antimicrobial stewardship intervention targeting patients with negative BCx
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study: 28187400

Group type: COMPARATOR
Intervention: Escitalopram plus placebo (SSRI monotherapy)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Bupropion plus escitalopram combination (bupropion-SSRI combination)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: CRP threshold based assignment
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Side effect burden
Number of subjects: 106
Study: 25274460

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Brisk Walking
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study: 22527138

Group type: EXPERIMENTAL
Intervention: Alfacalcidol + 500 mg calcium (group A)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Vitamin D + 1000 mg calcium (group B)
Number of subjects: 214
Study: 22073889

Group type: EXPERIMENTAL
Intervention: GA + 2 Hz‐EA
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GA + 100 Hz‐EA
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GA + 2 Hz/100 Hz‐EA
Number of subjects: 48

Group type: COMPARATOR
Intervention: RGA
Number of subjects: 48
Study: 19222323

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment over 17 weeks
Number of subjects: 99
Study: 17034444

Group type: EXPERIMENTAL
Intervention: Randomized response technique (RRT)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Direct interview techniques and voluntary questionnaires
Number of subjects: 500
Study: 14648310

Group type: EXPERIMENTAL
Intervention: Double-lumen totally implantable subcutaneous port system (PORT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Double-lumen central venous catheter (CVC)
Number of subjects: 43
Study: 11238504

Group type: EXPERIMENTAL
Intervention: Ghrelin (1.0 microg/kg i.v. at 0 min)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: GHRH (1.0 microg/kg i.v. at 0 min)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hexarelin (HEX) (1.0 microg/kg i.v. at 0 min)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ghrelin + GHRH
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (2 mL isotonic saline i.v. at 0 min)
Number of subjects: 7
Study: 9669256

Group type: EXPERIMENTAL
Intervention: Vitamin C (10 mg/min)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 66
Study: 8310993

Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (300 mg)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 3047335

Group type: EXPERIMENTAL
Intervention: Vincristine, cyclophosphamide, and doxorubicin (VCA) for six monthly cycles
Number of subjects: 229

Group type: COMPARATOR
Intervention: No further therapy (Control group)
Number of subjects: 229
Study: 29901736

Group type: EXPERIMENTAL
Intervention: LNS-LNS (Lipid-Based Nutrient Supplements for women and children)
Number of subjects: 4011

Group type: EXPERIMENTAL
Intervention: IFA-LNS (Iron and Folic Acid for women and LNS for children)
Number of subjects: 4011

Group type: EXPERIMENTAL
Intervention: LNS-LNS
Number of subjects: 4011

Group type: EXPERIMENTAL
Intervention: IFA-LNS
Number of subjects: 4011

Group type: EXPERIMENTAL
Intervention: IFA-MNP
Number of subjects: 4011

Group type: COMPARATOR
Intervention: IFA-Control
Number of subjects: 4011
Study: 27509141

Group type: EXPERIMENTAL
Intervention: Foot massage for 20 minutes after surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no foot massage)
Number of subjects: 70
Study: 25904634

Group type: EXPERIMENTAL
Intervention: Diagnostic criteria for a septate uterus (DC group)
Number of subjects: 191

Group type: COMPARATOR
Intervention: No diagnostic criteria (no DC group)
Number of subjects: 191
Study: 24385639

Group type: EXPERIMENTAL
Intervention: Reasoning training
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: First annual booster
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Training adherence
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Higher education, MMSE, better health, younger age
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Higher MMSE
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Initial training gain
Number of subjects: 699
Study: 20925074

Group type: EXPERIMENTAL
Intervention: Orally dissolving carbidopa/levodopa (OD C/L)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional oral carbidopa/levodopa
Number of subjects: 20
Study: 18202351

Group type: EXPERIMENTAL
Intervention: VF plus exercise
Number of subjects: 64

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 64

Group type: COMPARATOR
Intervention: VF alone
Number of subjects: 64
Study: 16723047

Group type: EXPERIMENTAL
Intervention: Clear plastic 'Anaesthetic Facemask'
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clear plastic 'Air Cushion Mask'
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Black antistatic reusable rubber facemask
Number of subjects: 60
Study: 14568963

Group type: EXPERIMENTAL
Intervention: Omega-3 lipid emulsion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Omega-6 lipid emulsion
Number of subjects: 12
Study: 11738543

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both sertraline and desipramine (responders)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both sertraline and desipramine (non-responders)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Clinical change (not medication)
Number of subjects: 16
Study: 9455594

Group type: EXPERIMENTAL
Intervention: Phonathon recruitment strategy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Printed media recruitment strategy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Word-of-mouth recruitment strategy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Remaining recruitment approaches
Number of subjects: 120
Study: 7930728

Group type: EXPERIMENTAL
Intervention: Colonized children (n=49)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Noncolonized children (n=108)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Frequency of colonization
Number of subjects: 157
Study: 3283426

Group type: EXPERIMENTAL
Intervention: Eledoisin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 0
Study: 31756189

Group type: EXPERIMENTAL
Intervention: 20% neem seed oil in coconut oil (NC)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 0.05% potassium permanganate (KMnO4) foot bath
Number of subjects: 96
Study: 28089184

Group type: EXPERIMENTAL
Intervention: Bone wax (2.5 g applied onto uncovered bone)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (electrocautery only)
Number of subjects: 100
Study: 26177518

Group type: EXPERIMENTAL
Intervention: IdeS (intravenous single ascending doses)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IdeS (0.24 mg/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IdeS
Number of subjects: 20
Study: 23261172

Group type: EXPERIMENTAL
Intervention: Lisinopril (40 mg/day) and a regular sodium diet (194 ± 49 mmol Na+/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Lisinopril plus valsartan (320 mg/day) and a low sodium diet (102 ± 52 mmol Na+/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Maximal treatment
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: PCSK9 at baseline
Number of subjects: 39
Study: 20958105

Group type: EXPERIMENTAL
Intervention: Targeted breastfeeding support in the hospital and via telephone
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Manual or electric breast pump used for 10-14 days
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 74

Group type: COMPARATOR
Intervention: No pump
Number of subjects: 74
Study: 19323664

Group type: EXPERIMENTAL
Intervention: Ebastine 20 mg
Number of subjects: 7
Study: 17582922

Group type: EXPERIMENTAL
Intervention: Zonisamide plus previous treatment
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo plus previous treatment
Number of subjects: 351
Study: 15044114

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (400 microg/day)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: MTHFR genotypes (CC or CT)
Number of subjects: 300

Group type: COMPARATOR
Intervention: MTHFR genotype TT
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Mean folate intake
Number of subjects: 300
Study: 11569889

Group type: EXPERIMENTAL
Intervention: Dolasetron 100 mg daily
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard therapy (ondansetron or granisetron)
Number of subjects: 62
Study: 9814477

Group type: EXPERIMENTAL
Intervention: R‐FSH (150 U)
Number of subjects: 9

Group type: COMPARATOR
Intervention: SB (steroid and LH free) after R‐FSH administration
Number of subjects: 9
Study: 8597984

Group type: EXPERIMENTAL
Intervention: Bactrim (sulphamethoxazole and trimethoprim)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 2527536

Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 12

Group type: COMPARATOR
Intervention: Frusemide
Number of subjects: 12
Study: 934535

Group type: EXPERIMENTAL
Intervention: Reserpine (1.5 mg/1.7 m2 surface) administered as a single i.m. injection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prolonged reserpine medication (0.2 mg reserpine 3 times a week for 6 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prolonged reserpine medication
Number of subjects: 30
Study: 30767748

Group type: EXPERIMENTAL
Intervention: Fasting during Ramadhan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dehydration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized trial
Number of subjects: 0
Study: 31377704

Group type: EXPERIMENTAL
Intervention: Telephone communication of benign biopsy results
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-person communication of benign biopsy results
Number of subjects: 0
Study: 28525788

Group type: EXPERIMENTAL
Intervention: Intervention for stimulant abuse/dependence
Number of subjects: 270
Study: 26105529

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (ECC2) on the ipsilateral leg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Eccentric exercise (ECC2) on the contralateral leg
Number of subjects: 26
Study: 22878222

Group type: EXPERIMENTAL
Intervention: Home-based exercise programme
Number of subjects: 70
Study: 20935256

Group type: EXPERIMENTAL
Intervention: Pathogen inactivated platelet components (PC‐Test)
Number of subjects: 645

Group type: COMPARATOR
Intervention: Conventional platelet components (Reference)
Number of subjects: 645
Study: 19646495

Group type: EXPERIMENTAL
Intervention: Exposure condition (chocolate craving manipulated)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Non-exposure condition
Number of subjects: 68
Study: 17294169

Group type: EXPERIMENTAL
Intervention: 3-day course of antibiotics and catheter replacement 4 hours after first antibiotic administration
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of care (no antibiotics, no catheter replacement)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3-day course of antibiotics and catheter replacement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 60
Study: 15153170

Group type: EXPERIMENTAL
Intervention: Orlistat (3 x 120 mg/day)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study: 11869760

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 9502305

Group type: EXPERIMENTAL
Intervention: Donjoy Legend brace
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bledsoe Brace Force III
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo brace
Number of subjects: 11
Study: 9120652

Group type: EXPERIMENTAL
Intervention: Mailed educational course on movement disorders
Number of subjects: 492

Group type: COMPARATOR
Intervention: Control group (did not receive the mailed CME course)
Number of subjects: 492
Study: 2048868

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin, 500 mg orally every 12 hours
Number of subjects: 801

Group type: COMPARATOR
Intervention: Norfloxacin, 400 mg orally every 12 hours
Number of subjects: 801
Study: 7236928

Group type: EXPERIMENTAL
Intervention: Frontalis EMG-biofeedback
Number of subjects: 40

Group type: COMPARATOR
Intervention: High expectations of cure (Control)
Number of subjects: 40
Study: 31094774

Group type: EXPERIMENTAL
Intervention: 5 mg amisulpride
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: 10 mg amisulpride
Number of subjects: 560

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 560
Study: 26547487

Group type: EXPERIMENTAL
Intervention: HyFoSy with ExEm foam
Number of subjects: 40

Group type: COMPARATOR
Intervention: HyCoSy with saline medium
Number of subjects: 40
Study: 25440791

Group type: EXPERIMENTAL
Intervention: Interdisciplinary palliative care intervention
Number of subjects: 200
Study: 23152584

Group type: EXPERIMENTAL
Intervention: Immunohistochemical assay of sarcolemmal chloride channel abundance using 2 different ClC1‐specific antibodies
Number of subjects: 0
Study: 20551460

Group type: EXPERIMENTAL
Intervention: Azathioprine 2.0-2.5 mg/kg/day
Number of subjects: 78

Group type: COMPARATOR
Intervention: Mesalazine 4 g/day
Number of subjects: 78
Study: 18614347

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol 250/50
Number of subjects: 782

Group type: COMPARATOR
Intervention: Salmeterol 50 microg
Number of subjects: 782
Study: 16371154

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg single dose in second trimester)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 12460041

Group type: EXPERIMENTAL
Intervention: Progressive resisted isotonic quadriceps and hamstrings exercise and training on a cycle ergometer three times weekly for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonprogressive program of range-of-motion exercises
Number of subjects: 0
Study: 10597763

Group type: EXPERIMENTAL
Intervention: 1 mg of phytonadione IV
Number of subjects: 22

Group type: COMPARATOR
Intervention: 1 mg of phytonadione SC
Number of subjects: 22
Study: 8751690

Group type: EXPERIMENTAL
Intervention: Tailored scan delay (group 2, n = 22)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard scan delay of 20 or 22 sec (group 1, n = 26)
Number of subjects: 48
Study: 1423955

Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem (20 mg followed by 25 mg bolus doses and 10 and 15 mg/hr infusion for 24 hours)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem
Number of subjects: 32
Study: 3869435

Group type: EXPERIMENTAL
Intervention: Nisoldipine (6 micrograms/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diltiazem (500 micrograms/kg)
Number of subjects: 0
Study: 31444189

Group type: EXPERIMENTAL
Intervention: Lifestyle treatment (information emphasising the disease's lifestyle causes)
Number of subjects: 738
Study: 29768319

Group type: EXPERIMENTAL
Intervention: Stress echocardiography
Number of subjects: 240

Group type: COMPARATOR
Intervention: Stress myocardial perfusion imaging (MPI)
Number of subjects: 240
Study: 26550945

Group type: EXPERIMENTAL
Intervention: Dilute vasopressin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dilute epinephrine
Number of subjects: 60
Study: 24499772

Group type: EXPERIMENTAL
Intervention: Whole Foods, plant-based, macrobiotic-style (n=22)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Moderate Fat with 10 g of ground flaxseed added daily (n=49)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Moderate Fat without 10 g of ground flaxseed added daily (n=49)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Moderate Fat group
Number of subjects: 71
Study: 20854868

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) applied over the dorsolateral prefrontal cortex using a 2 mA-current for 20 min, twice-daily, for 5 consecutive days.
Number of subjects: 31
Study: 20155617

Group type: EXPERIMENTAL
Intervention: Combination of carotenoids and myo‐inositol
Number of subjects: 0
Study: 17524594

Group type: EXPERIMENTAL
Intervention: High marking of the argumentative orientation and daily estimates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low marking of the argumentative orientation and yearly estimates
Number of subjects: 0
Study: 15212190

Group type: EXPERIMENTAL
Intervention: Tulobuterol TTS (Hokunalin Tape)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tulobuterol TTS (Hokunalin Tape) with inhalational steroids
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tulobuterol TTS (Hokunalin Tape) without inhalational steroids
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Inhalational steroids
Number of subjects: 24
Study: 11769150

Group type: EXPERIMENTAL
Intervention: FPD patch
Number of subjects: 22

Group type: COMPARATOR
Intervention: Direct suturing
Number of subjects: 22